Global IV Flush Syringe Market is valued at approximately USD XXX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Medical equipment called IV flush syringes are used to clean intravenous lines. Saline flushes are typically secure and well accepted by patients when performed appropriately. Despite their rarity, IV flush syringes have the potential to cause air embolisms, which can cause heart attacks, strokes, and respiratory failure. Syringe contamination has been connected to severe bacterial infections in patients. A severe allergic response might happen occasionally. The market is driven by key factors such as increasing number of hospital admissions and advanced healthcare infrastructure and increasing chronic disorders. According to AHA Hospital Statistics, 2022 edition, the total number of admissions to all hospitals in the United States was predicted to be 33,356,853. Since IV flush syringes are essential for administering medications and performing tests, there is an increasing need for the device in hospitals. Additionally, according to a poll by the American Hospital Association (AHA), there were 36,241,815 hospital admissions nationwide in 2019 and 36,30,000 in 2018. Furthermore, for example, according to estimates from the Centers for Disease Control and Prevention, there were 17,455,605 COPD diagnoses in the United States in 2020, and that number may rise in 2030. As a result, the country's rising COPD prevalence would increase hospital admission rates, requiring the use of IV flush syringes during the duration of therapy. Moreover, rise in product launches propels the market growth globally. However, increase in recalls of Flush syringes impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global IV Flush Syringe Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the overall market share owing to increasing cases of chronic diseases, rising number of surgical procedures performed. However, Asia Pacific is expected to be the fastest growing region due to growing hospital infrastructure and product launches during the projected years.

Major market players included in this report are:

Medtronic

Medline

Medefil

B. Braun

Cardinal Health

Aquabiliti

SteriCare Solution

Poly Medicure

Nipro Corporation

BD

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Saline

Heparin

By End-User:

Hospital

Clinic

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global IV Flush Syringe Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors